Marcos González-Díaz

11PUBLICATIONS
105CO-AUTHORS
AutoimmunityPredictive and prognostic markersLiquid biopsiesHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 19, 2026
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study.

Irene Dogliotti, Cristina Jiménez, Veronica Peri

|Aug 16, 2024
Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study.

J E Niño-Ramírez, M Alcoceba, M N Gutiérrez-Zufiaurre

|May 29, 2024
Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease.

Miguel Alcoceba, James P Stewart, María García-Álvarez

|Jul 28, 2023
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.

Charlotte Syrykh, Berta Pons-Brun, Núria Russiñol

|Oct 14, 2022
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia.

Catia Simoes, Maria-Carmen Chillon, David Martínez-Cuadrón

|Aug 16, 2022
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression.

Pau Abrisqueta, Daniel Medina, Guillermo Villacampa

Pageof 2

Frequent Collaborators

5 joint publications

Miguel Alcoceba

3 joint publications

Marta Crespo

3 joint publications

Maria-Carmen Chillon

3 joint publications

María García-Álvarez